Last quarter (Q4 2023), Adverum Biotechnologies's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Adverum Biotechnologies's net income was $-24.72M. See Adverum Biotechnologies’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 3.60M	$ 3.60M	-	$ 7.50M	$ 0.00	$ 250.00K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 5.00M	$ 3.60M	-	$ 7.50M	-	-
Operating Expense	$ 127.59M	$ 127.59M	$ 157.13M	$ -153.62M	$ 117.95M	$ 68.80M
Operating Income	$ -123.99M	$ -123.99M	$ -157.13M	$ -146.12M	$ -117.95M	$ -68.55M
Net Non Operating Interest Income Expense	-	-	-	$ 582.00K	-	-
Other Income Expense	$ -6.80M	$ -6.80M	$ -1.89M	$ 428.00K	$ 1.56M	$ 4.06M
Pretax Income	$ -118.24M	$ -118.24M	$ -154.46M	$ -145.54M	$ -116.39M	$ -64.49M
Tax Provision	$ -1.08M	$ -1.08M	$ 74.00K	-	$ 1.11M	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -118.10M	$ -117.17M	$ -155.32M	$ -145.97M	$ -117.51M	$ -64.49M
Basic EPS	$ -1.16	$ -1.16	$ -1.56	$ -1.48	$ -1.38	$ -1.01
Diluted EPS	$ -1.16	$ -1.16	$ -1.56	$ -1.48	$ -1.38	$ -1.01
Basic Average Shares	$ 403.30M	$ 100.82M	$ 99.25M	$ 98.04M	$ 85.15M	$ 64.10M
Diluted Average Shares	$ 403.30M	$ 100.82M	$ 99.25M	$ 98.04M	$ 85.15M	$ 64.10M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 127.59M	$ 127.59M	$ 157.13M	$ -153.62M	$ 117.95M	$ 68.80M
Net Income From Continuing And Discontinued Operation	$ -117.17M	$ -117.17M	$ -154.54M	$ -145.97M	$ -117.51M	$ -64.49M
Normalized Income	$ -76.60M	$ -119.10M	-	-	$ -117.51M	$ -64.49M
Interest Expense	-	-	-	-	-	-
EBIT	$ -118.24M	$ -118.24M	$ -154.46M	$ -145.54M	$ -117.95M	$ -68.55M
EBITDA	$ -101.51M	$ -101.51M	$ -148.81M	$ -138.13M	$ -113.79M	$ -66.97M

Currency in USD

Adverum Biotechnologies Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing